Delivery Order SPE2DB22D1106-SPE2DB24FFFC4

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a ceiling value of $3,406.81 and an ultimate completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Cosentyx (secukinumab) in 300mg doses. The contract has a ceiling value of $3,498.26 and a period of performance through April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (Secukinumab) 300 mg/2 mL injectable medication. The contract has a ceiling value of $3,910.45 and a period of performance through July 1, 2025. It is a Firm Fixed Price contract, indicating a set price for the delivery of the specified medication. The contract is not set-aside and is open to all qualified vendors....
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (Secukinumab), a 300 mg dose medication. The delivery order has a ceiling value of $33,301.39 and a completion date of June 6, 2025. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg medication. The delivery order, valued at $3,465.90, is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg/2 mL injections. The contract has a ceiling value of $7,820.90 and a period of performance through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg injections. The contract has a ceiling value of $7,793.90 and an ultimate completion date of August 1, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg dose syringes. The contract has a ceiling value of $49,439.68 and a period of performance through May 6, 2025. It is a firm-fixed-price contract, indicating a pre-determined unit price for the medication. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cosentyx, a specialty medication. The contract has a ceiling value of $8,669.55 and an ultimate completion date of July 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the pharmaceutical product Cosentyx (Secukinumab) 300 mg dose in 2 pre-filled syringes. The contract has a firm fixed price of $47,882.96 and a completion date of June 12, 2025. This delivery order is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFFC4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the specialty medication Cosentyx (Secukinumab) 300 mg dose. The contract has a total ceiling value of $7,904.77 and a period of performance through August 2, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract has a firm fixed-price pricing structure and does not utilize any small business set-aside designation.

Generated 10/31/24, 9:18 AM